These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4099595)

  • 1. [Influence of cyclic Ovosiston therapy on plasma lipid fractions of free cholesterol, total cholesterol and phospholipid].
    Carol W; Hempel E; Klinger G; Bünnig S
    Endokrinologie; 1970; 57(1):108-14. PubMed ID: 4099595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of a contraceptive treatment with Ovosiston on the serum-cholinesterase activity].
    Willgerodt H; Rothe K; Theile H; Fischer I
    Zentralbl Gynakol; 1971 Sep; 93(36):1261-7. PubMed ID: 4106443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive estrogen and plasma lipid levels.
    Hedlin A; Kuksis A; Geher K
    Obstet Gynecol; 1978 Oct; 52(4):430-5. PubMed ID: 714324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term effects of the estrogen-gestagen combination preparation Ovosiston on glucose level in the insulin tolerance test].
    Goretzlehner G; Rudolf K; Töwe J
    Zentralbl Gynakol; 1974 Oct; 96(40):1249-53. PubMed ID: 4141548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term effect of hormonal contraceptives on the behavior of serum lipids].
    Klinger G; Carol W; Hoppe H; Müller B; Bonow A
    Zentralbl Gynakol; 1977; 99(5):271-6. PubMed ID: 194435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A gradual method for a more physiological hormonal contraception].
    Hamann B; Büchner C
    Zentralbl Gynakol; 1976; 98(23):1445-9. PubMed ID: 65068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertility control with 15-8-5.
    Andelman MB
    Fertil Steril; 1970 Apr; 21(4):314-21. PubMed ID: 4101384
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of the oral contraceptive Ovosiston on the composition of human milk.
    Ramadan MA; Salah MM; Eid SZ; Sammour MB
    J Reprod Med; 1972 Aug; 9(2):81-3. PubMed ID: 4115112
    [No Abstract]   [Full Text] [Related]  

  • 9. [Liver function studies under the influence of hormonal contraceptives (sequential preparations)].
    Brügmann E; Göretzlehner G; Dabels J; Töwe J
    Dtsch Z Verdau Stoffwechselkr; 1979; 39(2):69-74. PubMed ID: 88322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in plasma lipids caused by oral contraceptives].
    Kaffarnik H
    Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:67-72. PubMed ID: 4114609
    [No Abstract]   [Full Text] [Related]  

  • 11. [Endometrium during administration of sequence-ovosiston (report on 3 variants of sequential therapy)].
    Böhm W; Hempel E; Klinger G; Carol W
    Zentralbl Gynakol; 1972 Dec; 94(52):1816-20. PubMed ID: 4119792
    [No Abstract]   [Full Text] [Related]  

  • 12. [The serum levels of nonesterified fatty acids and free amino acids under the effect of the oral contraceptive, Ovosiston].
    Methfessel HD; Mlytz H; Liedtke MP; Löffler F; Methfessel G
    Z Arztl Fortbild (Jena); 1970 Sep; 64(17):880-2. PubMed ID: 4098228
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of estrogen-gestagen drug combinations on carbohydrate and lipid metabolism. I. Effect of Ovosiston].
    Göretzlehner G; Herre HD; Töwe J
    Zentralbl Gynakol; 1973 Apr; 95(16):529-36. PubMed ID: 4123733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiences with different doses of Ovosiston preparations within the scope of marital and sexual counseling. Individual therapy with oral contraceptives].
    Ebeling K; Kühndel K; Rothe K
    Dtsch Gesundheitsw; 1971 Jan; 26(1):31-4. PubMed ID: 4106517
    [No Abstract]   [Full Text] [Related]  

  • 15. [Behavior of serum copper and iron under the influence of the ovulation inhibitor Ovosiston].
    Methfessel HD; Mlytz H; Methfessel G; Löffler F
    Z Gesamte Inn Med; 1969 Oct; 24(19):659-61. PubMed ID: 4188438
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of injectable contraceptive on lipid metabolism in women.
    Kandeel KM; Nayel SA; Abaza MS
    Biomed Biochim Acta; 1984; 43(1):111-5. PubMed ID: 6721873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endometrium in "contraception cycle" under Ovosiston].
    Böhm W; Möbius W; Müller W
    Zentralbl Gynakol; 1969 Oct; 91(43):1412-8. PubMed ID: 4100318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [1st clinical experiences on the use of oral contraceptive Ovosiston in diabetics].
    Gödel E; Gödel B
    Dtsch Gesundheitsw; 1970 Apr; 25(14):627-31. PubMed ID: 4098543
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experiences with Ovosiston for inhibition of ovulation].
    Kühne D
    Dtsch Gesundheitsw; 1966 Feb; 21(8):377-9. PubMed ID: 4165201
    [No Abstract]   [Full Text] [Related]  

  • 20. [Towards a more physiological hormonal contraception].
    Stĕrba R
    Zentralbl Gynakol; 1970 Mar; 92(10):303-12. PubMed ID: 4096927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.